A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study
PEC Innovation · 2025-06 · 6 · 100364
DOI: 10.1016/j.pecinn.2024.100364 ↗Kurz gefasst
Fachartikel in der Zeitschrift PEC Innovation, 2025-06. Verfasst von Joseph W Lanario und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, University of Plymouth, Plymouth, United Kingdom. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute for Health and Care Research, GlaxoSmithKline.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
- Department of Respiratory Medicine, Royal Devon and Exeter Hospital, University of Exeter, Exeter, United Kingdom.
- University of Exeter, Royal Devon and Exeter Hospital, Exeter, United Kingdom.
Förderung
- National Institute for Health and Care Research
- GlaxoSmithKline
Zitieren
APA
Lanario, J. W., Davies, D., Cartwright, L., Hyland, M. E., & Masoli, M. (2025). A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study. PEC Innovation, 6, 100364. https://doi.org/10.1016/j.pecinn.2024.100364
Vancouver
Lanario JW, Davies D, Cartwright L, Hyland ME, Masoli M. A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study. PEC Innovation. 2025;6:100364. doi:10.1016/j.pecinn.2024.100364
BibTeX
@article{Lanario2025,
author = {Lanario, Joseph W and Davies, Drew and Cartwright, Lucy and Hyland, Michael E and Masoli, Matthew},
title = {A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study},
journal = {PEC Innovation},
year = {2025},
volume = {6},
pages = {100364},
doi = {10.1016/j.pecinn.2024.100364}
}
EUVIMED